Clinical and experimental studies indicate that levels of IgM anti-PC are inversely correlated with cardiovascular disease progression [15] and that IgM anti-PC may mediate atheroprotection by neutralizing the proinflammatory properties of oxLDL [4, 5]. The gene discussed is CD40LG; the disease is cardiovascular disorder.